Neuropathy is a common complication of Type 1 and Type 2 diabetes. In the p
eripheral nerve, persistent hyperglycaemia leads to metabolic and vascular
disorders responsible for nerve fibre abnormalities. Genetic predisposition
has been mentioned more recently. Among metabolic factors, an increase of
the polyol pathway, a linoleic acid metabolism abnormality, a decrease of c
arnitine level; an in crease of protein glycation, nerve growth factor abno
rmalities, and high production of oxygen free radicals can be involved. The
se factors could account for nerve membrane phospholipid pattern disorder,
a decrease of Na/K ATPase activity and disequilibrium in prostaglandin prod
uction. Vascular factors involve a decrease in nitric oxide production, an
abnormality of eicosanoid production, and an increase in the oxidative path
way, inducing vasoconstriction of endoneural microvascularisation and nerve
hypoxia. Strong interactions exist between metabolic and Vascular factors,
making it difficult to distinguish between them. Moreover, a restriction p
olymorphism in the first intron of the Na/K ATPase ATP1 Al gene is associat
ed with low enzymatic activity and a relative risk of neuropathy of 6.5. El
ectromyography determines the myelinisation state of large nerve fibres and
the number of functional axons. However, it cannot detect damage to small
fibres, and the study of sensitive nerves is difficult. Electromyography is
not a systematic examination and should be preceeded by a clinical examina
tion of sensitivity.